Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cluster of differentiation 24 (CD24), also known as heat-stable antigen, is a cell surface glycoprotein that functions as a costimulatory molecule and cell adhesion molecule in immune regulation. The protein consists of a small 27-amino acid protein core with extensive glycosylation, and is expressed by hematopoietic cells, B lymphocytes, and activated T lymphocytes[1][5]. CD24 provides CD28-independent costimulation for T cell activation and clonal expansion, serving as a critical checkpoint in both normal immune responses and autoimmune disease development[5]. The molecule is particularly significant in autoimmune neurological diseases, where it has been identified as a therapeutic target; blocking CD24 interactions through soluble fusion proteins can ameliorate disease even after autoreactive T cells have been primed[5]. CD24 represents an attractive therapeutic target for autoimmune conditions because it acts as a checkpoint molecule distinct from classical costimulatory pathways, offering a novel approach for immune intervention in diseases such as multiple sclerosis[5].
CD24 operates as a costimulatory checkpoint molecule. Research indicates that HSA provides CD28-independent costimulation for clonal expansion of T cells. Notably, studies demonstrate that both T cells and non-T cells must express HSA for pathogenic T cells to execute their effector function in autoimmune disease models. A fusion protein (HSAIg) consisting of the extracellular domain of HSA and the Fc portion of immunoglobulin can block HSA-mediated interactions and drastically ameliorate disease signs even after self-reactive T cells have been expanded and activated.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cluster of differentiation 24 (CD24) (CD24).